Xtl Biopharmaceuticals (XTLB) Enterprise Value (QoQ) (2009 - 2024)
Xtl Biopharmaceuticals (XTLB) Enterprise Value (QoQ) (2009 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Xtl Biopharmaceuticals | 2.60 Bn | 2.60 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 33.55% |
| Sep 30, 2024 | -8.45% |
| Jun 30, 2024 | 32.19% |
| Mar 31, 2024 | -16.60% |
| Dec 31, 2023 | 9.07% |
| Sep 30, 2023 | 7.43% |
| Jun 30, 2023 | 17.14% |
| Mar 31, 2023 | 22.71% |
| Dec 31, 2022 | -67.16% |
| Sep 30, 2022 | 56.83% |
| Jun 30, 2022 | -84.67% |
| Mar 31, 2022 | 54.43% |
| Dec 31, 2021 | -103.49% |
| Sep 30, 2021 | 52.18% |
| Jun 30, 2021 | -85.53% |
| Mar 31, 2021 | 43.83% |
| Dec 31, 2020 | -61.03% |
| Sep 30, 2020 | 1.55% |
| Jun 30, 2020 | 10.48% |
| Mar 31, 2020 | 36.73% |